Stockhub

Amarantus BioScience Holdings, Inc.: Revision history

View logs for this page

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

13 August 2022

11 August 2022

26 July 2022

  • curprev 16:5816:58, 26 July 2022‎ Chris talk contribs‎ 1,715 bytes +1,715‎ Created page with "Amarantus BioScience Holdings, Inc., a biopharmaceutical company, focuses on the development of diagnostic and therapeutic product candidates in the areas of neurology, psychiatry, ophthalmology, and regenerative medicine. The company's diagnostic products in development include the lymphocyte proliferation (LymPro) test, a diagnostic blood test for Alzheimer's disease; and MSPrecise, a proprietary DNA sequencing assay for the identification of patients with multiple scl..." Tag: Visual edit
Retrieved from ‘https://stockhub.co/research/Amarantus_BioScience_Holdings,_Inc.’